Insider Selling: HealthStream (NASDAQ:HSTM) EVP Sells $72,240.00 in Stock

HealthStream, Inc. (NASDAQ:HSTM) EVP Kevin O’hara sold 3,000 shares of the business’s stock in a transaction that occurred on Wednesday, May 20th. The stock was sold at an average price of $24.08, for a total transaction of $72,240.00. Following the completion of the sale, the executive vice president owned 20,982 shares in the company, valued at $505,246.56. The trade was a 12.51% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

HealthStream Price Performance

NASDAQ HSTM opened at $23.81 on Friday. The company’s 50 day simple moving average is $21.59 and its 200 day simple moving average is $22.42. HealthStream, Inc. has a 12 month low of $19.50 and a 12 month high of $29.63. The company has a market capitalization of $695.73 million, a P/E ratio of 35.54, a PEG ratio of 2.68 and a beta of 0.41.

HealthStream (NASDAQ:HSTM) last released its earnings results on Monday, May 4th. The technology company reported $0.20 EPS for the quarter, topping analysts’ consensus estimates of $0.16 by $0.04. HealthStream had a net margin of 6.39% and a return on equity of 6.47%. The business had revenue of $81.20 million for the quarter, compared to the consensus estimate of $79.68 million. On average, analysts anticipate that HealthStream, Inc. will post 0.74 earnings per share for the current year.

HealthStream announced that its board has approved a share repurchase program on Friday, March 13th that allows the company to repurchase $10.00 million in outstanding shares. This repurchase authorization allows the technology company to purchase up to 1.7% of its stock through open market purchases. Stock repurchase programs are often a sign that the company’s board of directors believes its shares are undervalued.

HealthStream Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 29th. Investors of record on Monday, May 18th will be issued a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date is Monday, May 18th. HealthStream’s payout ratio is presently 20.90%.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on HSTM. Canaccord Genuity Group lifted their target price on shares of HealthStream to $24.00 and gave the stock a “hold” rating in a research report on Wednesday, May 6th. Weiss Ratings downgraded shares of HealthStream from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Wednesday. Finally, Wall Street Zen raised shares of HealthStream from a “hold” rating to a “buy” rating in a research report on Saturday, May 9th. Two investment analysts have rated the stock with a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock has an average rating of “Reduce” and a consensus price target of $24.00.

Institutional Trading of HealthStream

A number of institutional investors have recently added to or reduced their stakes in HSTM. Copeland Capital Management LLC lifted its stake in HealthStream by 43.8% in the first quarter. Copeland Capital Management LLC now owns 1,276,739 shares of the technology company’s stock valued at $26,441,000 after acquiring an additional 389,186 shares during the last quarter. JPMorgan Chase & Co. lifted its stake in HealthStream by 302.0% in the second quarter. JPMorgan Chase & Co. now owns 247,905 shares of the technology company’s stock valued at $6,860,000 after acquiring an additional 186,231 shares during the last quarter. Lazard Asset Management LLC lifted its stake in HealthStream by 268.2% in the first quarter. Lazard Asset Management LLC now owns 157,208 shares of the technology company’s stock valued at $3,256,000 after acquiring an additional 114,511 shares during the last quarter. Qube Research & Technologies Ltd lifted its stake in HealthStream by 77.3% in the second quarter. Qube Research & Technologies Ltd now owns 251,953 shares of the technology company’s stock valued at $6,972,000 after acquiring an additional 109,883 shares during the last quarter. Finally, Dimensional Fund Advisors LP lifted its stake in HealthStream by 6.4% in the first quarter. Dimensional Fund Advisors LP now owns 1,456,043 shares of the technology company’s stock valued at $30,156,000 after acquiring an additional 87,177 shares during the last quarter. 69.58% of the stock is currently owned by institutional investors and hedge funds.

About HealthStream

HealthStream, Inc is a Nashville, Tennessee–based provider of workforce development and learning management solutions for healthcare organizations. Since its founding in 1990, the company has focused on helping hospitals, clinics and other care providers streamline staff training, ensure regulatory compliance and monitor employee performance. HealthStream’s platform integrates online courses, skill competency assessments and credential management tools to support workforce readiness across the healthcare continuum.

The company’s core offerings include a learning management system (LMS) designed specifically for clinical and nonclinical personnel, a competency management suite that tracks skill acquisition and validation, and a content library featuring evidence-based clinical and compliance training modules.